|
Market Cap (1-Jul) $2,416,092 (1,016th) |
Close (30-Jun) $0.016 |
Volume (30-Jun) 5,525,026 |
Shortsold (24-Dec) 11,970 (0.01%) (590th) |
|
52w High $0.082 |
52w Low $0.011 |
P/E - |
EPS -0.05 |
IBX released this announcement to the ASX on 20 October 2020, 17:08. The announcement is not marked as price sensitive, and is 17 page(s) in length and 325.69kb in size.
You can view all announcements from IBX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IBX was 0.004% short sold according to ASIC data. It was ranked the 534th most shorted stock on the ASX. It remains ranked 590th as of the latest reported data (24 December 2024).
| Other Recent Announcements from IBX | |
|---|---|
| Expanded collaboration with Siemens Healthineers to US | 28 June 2023, 8:49 |
| Imagion to complete the MagSense HER2 Phase 1 Study | 21 June 2023, 8:27 |
| Imagion Announces New CEO | 19 June 2023, 8:31 |
| Notification regarding unquoted securities - IBX | 1 June 2023, 13:17 |
| Notification regarding unquoted securities - IBX | 1 June 2023, 13:12 |
| Appendix 2A - Fully Paid Ordinary Shares | 20 October 2020, 17:08 |
| Imagion appoints Geoff Hollis as CFO | 19 October 2020, 8:17 |
You must be logged in to post a reply.
Imagion Biosystems 